title: Fenretinide and risk reduction of second breast cancer.
authors.affiliation: E.O. Ospedali Galliera, Division of Medical Oncology, Via Volta 6, Genoa 16128, Italy. andrea.decensi@galliera.it
authors.forename: Andrea
authors.initials: A
authors.lastname: Decensi
authors.forename: Silvia
authors.initials: S
authors.lastname: Zanardi
authors.forename: Alessandra
authors.initials: A
authors.lastname: Argusti
authors.forename: Bernardo
authors.initials: B
authors.lastname: Bonanni
authors.forename: Alberto
authors.initials: A
authors.lastname: Costa
authors.forename: Umberto
authors.initials: U
authors.lastname: Veronesi
mesh_terms: D000328:Adult; D000368:Aged; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control* / Q000601:surgery; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000517:prevention & control* / Q000601:surgery; D005260:Female; D017313:Fenretinide / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D016588:Anticarcinogenic Agents; D017313:Fenretinide